People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Software / Tech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ROM Technologies, Inc. | — | Software / Tech | Growth/Late | $952.2M | $62.8M | 2015 |
| O2 Medtech Inc | — | Biotechnology | Seed | $7.1M | $160.3M | 2010 |
Gordon Hull at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gordon Hull on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wayne Wu | 1 | 4 |
| Shih-Ping (Bob) Wang | 1 | 4 |
| John Pavlidis | 1 | 4 |
| Steve Siegel | 1 | 2 |
| Kevin Rooney | 1 | 2 |
| Robert Grant Edwards | 1 | 2 |
| Edwin Dearborn | 1 | 1 |
| Steve Seger | 1 | 1 |
| Zengpin Yu | 1 | 1 |
| Peter Arn | 1 | 1 |
| Sanford Gomberg | 1 | 1 |
| Michael Bissonnette | 1 | 1 |
| Alan Tucker | 1 | 1 |
| Mike Holston | 1 | 1 |
| Scott Freedman | 1 | 1 |
| Charles Parker | 1 | 1 |
| Paul Chan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.